259 related articles for article (PubMed ID: 31038382)
1. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
Luethi D; Kolaczynska KE; Walter M; Suzuki M; Rice KC; Blough BE; Hoener MC; Baumann MH; Liechti ME
J Psychopharmacol; 2019 Jul; 33(7):831-841. PubMed ID: 31038382
[TBL] [Abstract][Full Text] [Related]
2. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.
Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH
Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160
[TBL] [Abstract][Full Text] [Related]
3. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
4. Methylone pre-exposure differentially impacts the aversive effects of MDPV and MDMA in male and female Sprague-Dawley rats: Implications for abuse vulnerability.
Manke HN; Nelson KH; Huang S; Bailey JM; Bowman SK; Jones RA; Cerveny SE; Rice KC; Riley AL
Pharmacol Biochem Behav; 2022 Oct; 220():173470. PubMed ID: 36206863
[TBL] [Abstract][Full Text] [Related]
5. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
Harvey EL; Baker LE
Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
8. MDMA, Methylone, and MDPV: Drug-Induced Brain Hyperthermia and Its Modulation by Activity State and Environment.
Kiyatkin EA; Ren SE
Curr Top Behav Neurosci; 2017; 32():183-207. PubMed ID: 27677782
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats.
Huang PK; Aarde SM; Angrish D; Houseknecht KL; Dickerson TJ; Taffe MA
Drug Alcohol Depend; 2012 Nov; 126(1-2):168-75. PubMed ID: 22664136
[TBL] [Abstract][Full Text] [Related]
10. Effects of social interaction and warm ambient temperature on brain hyperthermia induced by the designer drugs methylone and MDPV.
Kiyatkin EA; Kim AH; Wakabayashi KT; Baumann MH; Shaham Y
Neuropsychopharmacology; 2015 Jan; 40(2):436-45. PubMed ID: 25074640
[TBL] [Abstract][Full Text] [Related]
11. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.
Baumann MH; Ayestas MA; Partilla JS; Sink JR; Shulgin AT; Daley PF; Brandt SD; Rothman RB; Ruoho AE; Cozzi NV
Neuropsychopharmacology; 2012 Apr; 37(5):1192-203. PubMed ID: 22169943
[TBL] [Abstract][Full Text] [Related]
12. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
Wakeford AGP; Sherwood AM; Prisinzano TE; Bergman J; Kohut SJ; Paronis CA
Int J Neuropsychopharmacol; 2021 Aug; 24(8):656-665. PubMed ID: 33909067
[TBL] [Abstract][Full Text] [Related]
13. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
Thomas AM; Cargile KJ; Lunn JA; Baker LE
Behav Pharmacol; 2021 Sep; 32(6):524-532. PubMed ID: 34397448
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
[TBL] [Abstract][Full Text] [Related]
15. Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
López-Arnau R; Martínez-Clemente J; Pubill D; Escubedo E; Camarasa J
Br J Pharmacol; 2012 Sep; 167(2):407-20. PubMed ID: 22509960
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxypyrovalerone (MDPV) induce differential cytotoxic effects in bovine brain microvessel endothelial cells.
Rosas-Hernandez H; Cuevas E; Lantz SM; Rice KC; Gannon BM; Fantegrossi WE; Gonzalez C; Paule MG; Ali SF
Neurosci Lett; 2016 Aug; 629():125-130. PubMed ID: 27320055
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.
Valente MJ; Bastos ML; Fernandes E; Carvalho F; Guedes de Pinho P; Carvalho M
ACS Chem Neurosci; 2017 Apr; 8(4):850-859. PubMed ID: 28067045
[TBL] [Abstract][Full Text] [Related]
19. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.
Risca HI; Baker LE
Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
